Life science reagents and forensic standards with in-house R&D and DEA licensing
Cayman Chemical supplies assay kits, antibodies, proteins, and biochemicals to research institutions globally, backed by 100 in-house scientists. The company is actively modernizing instrumentation and digitizing high-volume submission workflows—core operational challenges reflected in their current hiring mix across product, research, and quality roles. Their DEA licensure and ISO accreditations signal a compliance-heavy, regulated manufacturing operation.
Cayman Chemical manufactures and distributes research reagents and forensic analytical standards to academic institutions and licensed laboratories. Founded in 1980 and based in Ann Arbor, Michigan, the company operates a DEA-licensed production facility holding ISO/IEC 17025 and ISO 17034 accreditations. The portfolio spans cancer, inflammation, neuroscience, epigenetics, diabetes, and other therapeutic research areas, along with a specialized business in high-purity controlled substances for forensic analysis. Beyond product sales, the company offers contract research services and technical support via its in-house scientist team. With 201–500 employees, the company is mid-market, currently scaling product development and quality functions.
The company uses Microsoft Office (Excel, Word, PowerPoint), Microsoft Dynamics 365, SharePoint, Teams, HPLC, Chromeleon for chromatography workflows, EndNote for reference management, and Adobe Creative Suite. No adopting or replacing announcements in recent months.
Modernizing instrumentation workflows, digitizing high-volume submission processes, and technical writing efficiency. The company is also advancing growth strategy and conducting customer outreach for market research. These initiatives align with product and quality hiring acceleration.
Other companies in the same industry, closest in size